Norway· NO-ID_3F93570A-266A-401E-A7F2-CA1597459710
Sirolimus apotheke roter ochsen
A sirolimus product containing sirolimus, registered in Norway by Apotheke Roter Ochsen. The same ATC class is registered in 6 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Sirolimus is registered in 6 of 19 countries.
Countries holding a registration under ATC L01EG04 (sirolimus), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 4 of them publish a price we can compare per daily dose
Sirolimus · ATC L01EG04
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Japan
- Norwayprice
The record
At a glance
FEST (Norway)- Active substance
- Sirolimus
- Manufacturer
- Apotheke Roter Ochsen
- Country
- Norway (NO)
- ATC code
- L01EG04
- ATC class
- Sirolimus
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 2
- no_merkevare_idID_3F93570A-266A-401E-A7F2-CA1597459710
- no_varenummer29322630
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
737 interactions on record for sirolimus.
Graded by severity as the source publishes them — 162 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sirolimus · interactions on record
737 records
- 162 severe
- 441 moderate
- 8 minor
- 126 info
Most severe, free to view
- ClotrimazoleA01AB18severe
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sirolimus in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFYARROAadi Bioscience, Inc.
- United KingdomHyftor 2mg/g gelPlusultra Pharma UK Ltd
- CzechiaHYFTORPlusultra pharma GmbH, Düsseldorf
- SwitzerlandRapamune 0.5 mg, überzogene TablettenPfizer AG
- IrelandHYFTOR 2 mg/g GelPlusultra Pharma GmbH
- FinlandHyftorPlusultra Pharma GmbH
- PolandHyftorPlusultra pharma GmbH
- NetherlandsHyftor 2 mg/g gelPlusultra Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Germany · Sirolimus Panacea Biotec
- Iceland · Hyftor, Rapamune
- Liechtenstein · Hyftor, Rapamune
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cefb0cf4-4ad8-4468-a608-fe5f9208d6e4 GET /v1/drugs/cefb0cf4-4ad8-4468-a608-fe5f9208d6e4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem",
"source": "fest",
"status": "A",
"atc_name": "Sirolimus",
"merkevare_id": "ID_3F93570A-266A-401E-A7F2-CA1597459710",
"name_form_strength": "Sirolimus apotheke roter ochsen krem 1 %",
"prescription_group": "C"
}See everything about sirolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.